Boston Scientific (BSX) Consolidated Net Income (2009 - 2026)

Boston Scientific's Consolidated Net Income history runs 18 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Consolidated Net Income rose 99.11% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $3.6 billion (up 75.75% YoY), while the FY2025 annual figure was $2.9 billion, up 56.66% from the prior year.
• Consolidated Net Income came in at $1.3 billion for Q1 2026 at Boston Scientific, up from $670.0 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $1.3 billion in Q1 2026 to a low of $111.0 million in Q1 2022.
• A 5-year average of $492.3 million and a median of $493.0 million in 2024 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income slumped 67.45% in 2022 and soared 257.45% in 2023, its largest moves.
• Boston Scientific's Consolidated Net Income stood at $141.0 million in 2022, then jumped by 257.45% to $504.0 million in 2023, then climbed by 11.51% to $562.0 million in 2024, then increased by 19.22% to $670.0 million in 2025, then soared by 99.7% to $1.3 billion in 2026.
• According to Business Quant data, Consolidated Net Income over the past three periods registered $1.3 billion, $670.0 million, and $756.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison